Bifidobacterium longum subspecies infantis bacteremia in 3 extremely preterm infants receiving probiotics

Emerging Infectious Diseases

Volumn 22, Issue 9, 2016, Pages 1664-1666

  Esaiassen, Eirin ^a,b   Cavanagh, Pauline ^a   Hjerde, Erik ^b   Simonsen, Gunnar S ^a,b   Støen, Ragnhild ^c,d   Klingenberg, Claus ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL RADIOGRAPHY; BIFIDOBACTERIUM INFANTIS; CASE REPORT; DRUG WITHDRAWAL; ECHOGRAPHY; ENTEROCOCCUS FAECALIS; FEMALE; GENE SEQUENCE; HISTOLOGY; HUMAN; INFANT; LACTOBACILLUS ACIDOPHILUS; LETTER; MALE; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NECROTIZING ENTEROCOLITIS; PNEUMOPERITONEUM; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; BACTEREMIA; BACTERIAL GENOME; BIFIDOBACTERIALES INFECTION; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CLASSIFICATION; GENETICS; MICROBIOLOGY; NEWBORN; WHOLE GENOME SEQUENCING;

BACTEREMIA; BIFIDOBACTERIALES INFECTIONS; BIFIDOBACTERIUM LONGUM SUBSPECIES INFANTIS; FEMALE; GENOME, BACTERIAL; HUMANS; INFANT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; MALE; PROBIOTICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; WHOLE GENOME SEQUENCING;

EID: 84988442215     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2209.160033     Document Type: Letter

References (8)

1. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;4:CD005496.
2. Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr. 2014;164:980–5. http://dx.doi.org/10.1016/j.jpeds.2013.11.025
3. Härtel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr. 2014;165:285–9. http://dx.doi.org/10.1016/j.jpeds.2014.04.029
4. Jenke A, Ruf EM, Hoppe T, Heldmann M, Wirth S. Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Arch Dis Child Fetal Neonatal Ed. 2012;97:F217–8. http://dx.doi.org/10.1136/archdischild-2011-300838
5. Ohishi A, Takahashi S, Ito Y, Ohishi Y, Tsukamoto K, Nanba Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156:679–81. http://dx.doi.org/10.1016/j.jpeds.2009.11.041
6. Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology. 2015;107:56–9. http://dx.doi.org/10.1159/000367985
7. Bertelli C, Pillonel T, Torregrossa A, Prod’hom G, Fischer CJ, Greub G, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis. 2015;60:924–7. http://dx.doi.org/10.1093/cid/ciu946
8. Avcin SL, Pokorn M, Kitanovski L, Premru MM, Jazbec J. Bifidobacterium breve sepsis in child with high-risk acute lymphoblastic leukemia. Emerg Infect Dis. 2015;21:1674–5. http://dx.doi.org/10.3201/eid2109.150097